Eva Schlein
Uppsala, C 75185, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pretargeted brain PET imaging reveals amyloid-β pathology using a TCO-modified antibody and a fluorine-18-labeled tetrazine.
Journal: Translational neurodegeneration
Published: July 29, 2025
Fluorine-18 ImmunoPET Imaging of Antibody Brain Kinetics and Amyloid-Beta Pathology.
Journal: ACS pharmacology & translational science
Published: May 17, 2025
High-affinity transferrin receptor binding improves brain delivery of bispecific antibodies at tracer dose.
Journal: Fluids and barriers of the CNS
Published: May 04, 2025
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET.
Synthesis and evaluation of fluorine-18 labelled tetrazines as pre-targeting imaging agents for PET.
Journal: EJNMMI radiopharmacy and chemistry
Published: February 04, 2024
Functionalization of Radiolabeled Antibodies to Enhance Peripheral Clearance for High Contrast Brain Imaging.
Journal: Molecular pharmaceutics
Published: October 06, 2022
PET Imaging in Preclinical Anti-Aβ Drug Development.
Journal: Pharmaceutical research
Published: March 15, 2022
Improved synthesis of SV2A targeting radiotracer [11C]UCB-J.
Journal: EJNMMI radiopharmacy and chemistry
Published: September 09, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026